STAT+: Awaiting ‘definitive’ Alzheimer’s drug data, Roche and Genentech launch ambitious new study
Roche and Genentech are embarking on an ambitious clinical trial of their investigational Alzheimer's drug without waiting for data from key ongoing studies.
